Innate immunity and the regulation and mobilization of keratinocyte stem cells: Are the old players playing a new game?

Experimental Dermatology

Volumn 21, Issue 9, 2012, Pages 660-664

  Singh, Ashok ^a   Morris, Rebecca J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Innate immunity; Keratinocyte; Mobilization; Skin; Stem cells; Toll like receptor

Indexed keywords

ALPHA INTERFERON; ALPHA6 INTEGRIN; BETA INTERFERON; CD34 ANTIGEN; GAMMA INTERFERON; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 20; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ARTICLE; CELL SURVIVAL; CYTOKINE PRODUCTION; HAIR FOLLICLE; HEMATOPOIETIC STEM CELL; HUMAN; INNATE IMMUNITY; KERATINOCYTE STEM CELL; MESENCHYMAL STEM CELL; NONHUMAN; PROTEIN EXPRESSION; STEM CELL; STEM CELL MOBILIZATION;

ANTIGENS, CD34; CYTOKINES; ENDOTOXINS; HAIR FOLLICLE; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNITY, INNATE; INTEGRIN ALPHA6; KERATINOCYTES; MESENCHYMAL STROMAL CELLS; SIGNAL TRANSDUCTION; STEM CELLS; TOLL-LIKE RECEPTORS;

EID: 84865329292     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2012.01566.x     Document Type: Article

References (87)

1. Tizard I. Immunity at body surface. Philadelphia, PA: Saunders, 2000.
2. Trempus C S, Morris R J, Ehinger M et al. Cancer Res 2007: 67: 4173-4181.
3. Ito M, Liu Y, Yang Z et al. Nat Med 2005: 11: 1351-1354.
4. Morris R J, Liu Y, Marles L et al. Nat Biotechnol 2004: 22: 411-417.
5. Janeway C A Jr. Cold Spring Harb Symp Quant Biol 1989: 54: 1-13.
6. Akira S, Uematsu S, Takeuchi O. Cell 2006: 124: 783-801.
7. Barton G M, Kagan J C. Nat Rev Immunol 2009: 9: 535-542.
8. Aderem A, Ulevitch R J. Nature 2000: 406: 782-787.
9. Le Bourhis L, Benko S, Girardin S E. Biochem Soc Trans 2007: 35: 1479-1484.
10. de Koning H D, Rodijk-Olthuis D, van Vlijmen-Willems I M et al. J Invest Dermatol 2010: 130: 2611-2620.
11. Becker M N, Diamond G, Verghese M W et al. J Biol Chem 2000: 275: 29731-29736.
12. Cario E, Rosenberg I M, Brandwein S L et al. J Immunol 2000: 164: 966-972.
13. Faure E, Thomas L, Xu H et al. J Immunol 2001: 166: 2018-2024.
14. Muzio M, Bosisio D, Polentarutti N et al. J Immunol 2000: 164: 5998-6004.
15. Visintin A, Mazzoni A, Spitzer J H et al. J Immunol 2001: 166: 249-255.
16. Miller L S, Sorensen O E, Liu P T et al. J Immunol 2005: 174: 6137-6143.
17. Kollisch G, Kalali B N, Voelcker V et al. Immunology 2005: 114: 531-541.
18. Mempel M, Voelcker V, Kollisch G et al. J Invest Dermatol 2003: 121: 1389-1396.
19. Pivarcsi A, Bodai L, Rethi B et al. Int Immunol 2003: 15: 721-730.
20. Renn C N, Sanchez D J, Ochoa M T et al. J Immunol 2006: 177: 298-305.
21. Mempel M, Kalali B N, Ollert M et al. Dermatol Clin 2007: 25: 531-540.
22. Song P I, Park Y M, Abraham T et al. J Invest Dermatol 2002: 119: 424-432.
23. Muller-Decker K, Manegold G, Butz H et al. J Invest Dermatol 2005: 124: 553-561.
24. Trempus C S, Dang H, Humble M M et al. J Invest Dermatol 2007: 127: 2904-2907.
25. Leulier F, Lemaitre B. Nat Rev Genet 2008: 9: 165-178.
26. Naseemuddin M, Iqbal A, Nasti T H et al. Int J Cancer 2011: 130: 765-774.
27. Yusuf N, Nasti T H, Long J A et al. Cancer Res 2008: 68: 615-622.
28. Mittal D, Saccheri F, Venereau E et al. EMBO J 2010: 29: 2242-2252.
29. Grone A. Vet Immunol Immunopathol 2002: 88: 1-12.
30. Kocic J, Bugarski D, Santibanez J F. European journal of cancer (Oxford, England: 1990) 2011: 48: 1550-1557.
31. Sauder D N, Orr F W, Matic S et al. Immunol Lett 1989: 22: 123-127.
32. Kothny-Wilkes G, Kulms D, Poppelmann B et al. J Biol Chem 1998: 273: 29247-29253.
33. Darmstadt G L, Fleckman P, Rubens C E. J Infect Dis 1999: 180: 1718-1721.
34. Komine M, Rao L S, Freedberg I M et al. J Invest Dermatol 2001: 116: 330-338.
35. Niebuhr M, Heratizadeh A, Wichmann K et al. Exp Dermatol 2011: 20: 468-472.
36. Lee K H, Cho K A, Kim J Y et al. Exp Dermatol 2011: 20: 149-151.
37. Olaru F, Jensen L E. Exp Dermatol 2010: 19: e314-e316.
38. Ullrich S E. J Immunol 1994: 152: 3410-3416.
39. Beissert S, Hosoi J, Kuhn R et al. J Invest Dermatol 1996: 107: 553-557.
40. Ratajczak M Z, Kim C H, Wojakowski W et al. Leukemia 2010: 24: 1667-1675.
41. Lee H M, Wysoczynski M, Liu R et al. Leukemia 2010: 24: 573-582.
42. Ratajczak M Z, Lee H, Wysoczynski M et al. Leukemia 2010: 24: 976-985.
43. Lee H M, Wu W, Wysoczynski M et al. Leukemia 2009: 23: 2052-2062.
44. Nardini E, Morelli D, Aiello P et al. J Cell Physiol 2005: 204: 889-895.
45. Wong S Y, Reiter J F. Proc Nat Acad Sci USA 2011: 108: 4093-4098.
46. Ratajczak M Z, Kim C. Expert opinion on biological therapy 2012: 12: 287-297.
47. Keating G M. Drugs 2011: 71: 1623-1647.
48. Lieschke G J, Burgess A W. N Engl J Med 1992: 327: 99-106.
49. Tong J, Gordon M S, Srour E F et al. Blood 1993: 82: 784-791.
50. Brasel K, McKenna H J, Morrissey P J et al. Blood 1996: 88: 2004-2012.
51. Fibbe W E, Pruijt J F, Velders G A et al. Ann N Y Acad Sci 1999: 872: 71-82.
52. Ganser A, Lindemann A, Seipelt G et al. Blood 1990: 76: 1287-1292.
53. Laterveer L, Lindley I J, Heemskerk D P et al. Blood 1996: 87: 781-788.
54. Velders G A, van Os R, Hagoort H et al. Blood 2004: 103: 340-346.
55. Cline M J, Golde D W. Exp Hematol 1977: 5: 186-190.
56. Vos O, Wilschut I J. Cell Tissue Kinet 1979: 12: 257-267.
57. Meyrick B O, Ryan U S, Brigham K L. Am J Pathol 1986: 122: 140-151.
58. Schletter J, Heine H, Ulmer A J et al. Arch Microbiol 1995: 164: 383-389.
59. Shi C, Jia T, Mendez-Ferrer S et al. Immunity 2011: 34: 590-601.
60. Boiko J R, Borghesi L. Cytokine 2011: 57: 1-8.
61. Baldridge M T, King K Y, Boles N C et al. Nature 2010: 465: 793-797.
62. Baldridge M T, King K Y, Goodell M A. Trends Immunol 2011: 32: 57-65.
63. Blanpain C, Lowry W E, Geoghegan A et al. Cell 2004: 118: 635-648.
64. Taylor G, Lehrer M S, Jensen P J et al. Cell 2000: 102: 451-461.
65. Locksley R M, Killeen N, Lenardo M J. Cell 2001: 104: 487-501.
66. Pearson G, Robinson F, Beers Gibson T et al. Endocr Rev 2001: 22: 153-183.
67. Beutler B, Greenwald D, Hulmes J D et al. Nature 1985: 316: 552-554.
68. Jiang Z, Johnson H J, Nie H et al. J Biol Chem 2003: 278: 10952-10956.
69. Schauvliege R, Janssens S, Beyaert R. J Cell Mol Med 2007: 11: 453-461.
70. Kawai K, Shimura H, Minagawa M et al. J Dermatol Sci 2002: 30: 185-194.
71. Ito T. J Dermatol Sci 2010: 60: 67-73.
72. Petukhova L, Duvic M, Hordinsky M et al. Nature 2010: 466: 113-117.
73. Sellheyer K, Atanaskova-Mesinkovska N, Nelson P et al. Br J Dermat 2011: 165: 1149-1151.
74. Amoh Y, Maejima H, Niiyama S et al. EJD 2011: 21: 209-212.
75. Nagai Y, Garrett K P, Ohta S et al. Immunity 2006: 24: 801-812.
76. Kim J M, Kim N I, Oh Y K et al. Int Immunol 2005: 17: 1525-1531.
77. Ratajczak M Z, Liu R, Ratajczak J et al. Differentiation 2011: 81: 153-161.
78. Reca R, Mastellos D, Majka M et al. Blood 2003: 101: 3784-3793.
79. Vija L, Farge D, Gautier J F et al. Diabetes Metab 2009: 35: 85-93.
80. Di Nicola M, Carlo-Stella C, Magni M et al. Blood 2002: 99: 3838-3843.
81. Anzalone R, LoIacono M, Loria T et al. Stem Cell Rev 2011: 7: 342-363.
82. Pittenger M. Cell Stem Cell 2009: 5: 8-10.
83. Nervi B, Link D C, DiPersio J F. J Cell Biochem 2006: 99: 690-705.
84. Sasaki M, Abe R, Fujita Y et al. J Immunol 2008: 180: 2581-2587.
85. Wu Y, Chen L, Scott P G et al. Stem Cells 2007: 25: 2648-2659.
86. Deng W, Han Q, Liao L et al. Tissue Eng 2005: 11: 110-119.
87. Sotiropoulou P A, Candi A, Mascre G et al. Nat Cell Biol 2010: 12: 572-582.